These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 25571897)
1. Clinical significance of CD44s, CD44v3 and CD44v6 in breast cancer. Wu XJ; Li XD; Zhang H; Zhang X; Ning ZH; Yin YM; Tian Y J Int Med Res; 2015 Apr; 43(2):173-9. PubMed ID: 25571897 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component. Umeda T; Ishida M; Murata S; Mori T; Kawai Y; Itoi N; Tomida K; Tanaka A; Sakai S; Kitamura M; Kubota Y; Kushima R; Tani M Breast Cancer; 2016 Nov; 23(6):869-875. PubMed ID: 26494575 [TBL] [Abstract][Full Text] [Related]
3. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma. Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228 [TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625 [TBL] [Abstract][Full Text] [Related]
5. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Afify A; Purnell P; Nguyen L Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378 [TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids. Afify A; Pang L; Howell L Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):446-50. PubMed ID: 18091389 [TBL] [Abstract][Full Text] [Related]
8. [Expression of standard and variant CD44 in human lung cancer]. Zhao H; Fang J; Du G Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506 [TBL] [Abstract][Full Text] [Related]
9. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma. Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576 [TBL] [Abstract][Full Text] [Related]
10. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Gong Y; Sun X; Huo L; Wiley EL; Rao MS Histopathology; 2005 Jan; 46(1):24-30. PubMed ID: 15656882 [TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study. Morris SF; O'Hanlon DM; McLaughlin R; McHale T; Connolly GE; Given HF Eur J Surg Oncol; 2001 Sep; 27(6):527-31. PubMed ID: 11520083 [TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of adhesive molecule CD44v6 in breast invasive ductal carcinoma]. Lian ZQ; Yang MT; Hou JH; Luo RZ; Wang X; Tang J Ai Zheng; 2006 Oct; 25(10):1291-5. PubMed ID: 17059779 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas. Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890 [TBL] [Abstract][Full Text] [Related]
14. Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast. Afify A; McNiel MA; Braggin J; Bailey H; Paulino AF Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):121-7. PubMed ID: 18227732 [TBL] [Abstract][Full Text] [Related]
15. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast. Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796 [TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M; Lee HK; Kang YK Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy. Aaltomaa S; Lipponen P; Viitanen J; Kankkunen JP; Ala-Opas M; Kosma VM Eur Urol; 2000 Nov; 38(5):555-62. PubMed ID: 11096236 [TBL] [Abstract][Full Text] [Related]
18. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. Liu YJ; Yan PS; Li J; Jia JF World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351 [TBL] [Abstract][Full Text] [Related]
19. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy]. Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic significance of expression of CD44s and CD44v6 isoforms in squamous cell carcinoma of the supraglottic larynx. Rodrigo JP; Domínguez F; Alvarez C; González MV; Herrero A; Suárez C Am J Clin Pathol; 2002 Jul; 118(1):67-72. PubMed ID: 12109858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]